openPR Logo
Press release

Puttist II Launches on Indiegogo to Help Golfers Kill 3-Putts for Good

04-18-2025 11:34 PM CET | Arts & Culture

Press release from: ABNewswire

Puttist II Launches on Indiegogo to Help Golfers Kill 3-Putts

Revolutionary new putting platform offers 60ft-long practice at home with just one ball, real-time feedback, and customizable green speeds
Mukilteo, United States - Golfers, rejoice. Say goodbye to frustrating three-putts and hello to precision putting. The team behind the popular Puttist putting aid has officially unveiled the Puttist II, a next-generation smart putting platform designed to eliminate 3-putts, refine technique, and bring pro-level training into your home or office. The project is now live on Indiegogo with exclusive early-backer perks.

Whether you're prepping for your next tournament or just want to sink more putts on weekend rounds, Puttist II is here to revolutionize your game.

"We wanted to create a tool that not only helps golfers get better but makes practice more engaging and effective," said Douglas Kim, creator of Puttist II. "With features like 60-foot-long putting capability, real-time stroke analysis, and customizable green speeds, we've built something that serious golfers can truly rely on."

In Memory of a Putting Legend

PUTTIST mourns the passing of Dave Pelz, author of The Putting Bible . PUTTIST was born in 2010 after reading his book and being inspired by his insights-particularly his emphasis on the importance of distance control. That idea sparked the journey to develop a way for amateur golfers to practice consistently and effectively every day. That vision lives on through PUTTIST II. RIP, Mr. Pelz.

Key Features of Puttist II:

Real-Time Feedback: Precision sensors track every stroke to help golfers identify flaws and improve faster.

Customizable Green Speeds: Simulate everything from slow greens to fast tournament conditions.

Train Anywhere: Compact, portable design fits into any room, office, or garage.

Build Muscle Memory: Designed to develop consistent, repeatable putting mechanics.

60-Foot Putting Practice-At Home, With Just One Ball: A game-changing addition, Puttist II enables golfers to practice long-distance lag putts without needing a ball return or extended space.

Early supporters on Indiegogo will gain access to limited-time discounts, exclusive bundles, and early delivery of the product. The Indiegogo campaign is live now at:

https://www.indiegogo.com/projects/puttist-ii-a-new-putting-platform-to-kill-3 [https://www.indiegogo.com/projects/puttist-ii-a-new-putting-platform-to-kill-3putts/coming_soon]putts/coming_soon [https://www.indiegogo.com/projects/puttist-ii-a-new-putting-platform-to-kill-3putts/coming_soon]

About Puttist

Puttist is a leader in golf training innovation, committed to helping golfers at every level unlock their true potential on the green. With a focus on smart design, real performance data, and user-friendly tools, Puttist continues to push the boundaries of at-home golf training.

Media Contact
Company Name: Puttist
Contact Person: Douglas Kim CEO
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=puttist-ii-launches-on-indiegogo-to-help-golfers-kill-3putts-for-good]
Country: United States
Website: https://www.indiegogo.com/projects/puttist-ii-a-new-putting-platform-to-kill-3 putts/coming_soon

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Puttist II Launches on Indiegogo to Help Golfers Kill 3-Putts for Good here

News-ID: 3978028 • Views:

More Releases from ABNewswire

Glioma Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Glioma Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in …
DelveInsight's "Glioma Pipeline Insight, 2025" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the glioma pipeline landscape. It covers the Glioma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Glioma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest drugs and treatment options in the Glioma
Hemophagocytic Lymphohistiocytosis Clinical Trial Pipeline Appears Robust With 5+ Key Pharma Companies Actively Working in the Domain | DelveInsight
Hemophagocytic Lymphohistiocytosis Clinical Trial Pipeline Appears Robust With 5 …
DelveInsight's, "Hemophagocytic Lymphohistiocytosis Pipeline Insights 2025" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Hemophagocytic Lymphohistiocytosis pipeline landscape. It covers the Hemophagocytic Lymphohistiocytosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hemophagocytic Lymphohistiocytosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Download DelveInsight's comprehensive Hemophagocytic Lymphohistiocytosis Pipeline Report
Mantle Cell Lymphoma Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight
Mantle Cell Lymphoma Clinical Trial Pipeline Appears Robust With 20+ Key Pharma …
DelveInsight's, "Mantle Cell Lymphoma Pipeline Insight, 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Mantle Cell Lymphoma pipeline landscape. It covers the Mantle Cell Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Mantle Cell Lymphoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Click here to
Myositis Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Roche, Pfizer, Zydus Group, Lupin, Bausch Health, Accord Healthcare, Genentech
Myositis Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Co …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Myositis pipeline constitutes 18+ key companies continuously working towards developing 20+ Myositis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Myositis Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Myositis Market. The Myositis Pipeline report embraces in-depth commercial and clinical assessment

All 5 Releases